Pronóstico del mercado de fraccionamiento de plasma de Asia Pacífico hasta 2028: impacto de COVID-19 y análisis regional por producto (inmunoglobulina, albúmina, concentrados de factor de coagulación, inhibidores de proteasa y otros productos plasmáticos), aplicación (neurología, inmunología, hematología, cuidados intensivos, neumología y Otras aplicaciones) y usuario final (hospitales y clínicas, laboratorios de investigación clínica e institutos académicos)
Introducción al mercado
APAC es el mercado de más rápido crecimiento para el fraccionamiento de plasma, y China, India, Japón, Corea del Sur, Australia y el resto de APAC son los principales contribuyentes al mercado en esta región. APAC representó una participación de mercado significativa en el mercado mundial de fraccionamiento de plasma en 2021 debido al creciente interés de los actores internacionales en China e India, el apoyo gubernamental en países como China y el avance de la infraestructura sanitaria. Por lo tanto, la región tiene un enorme potencial para que los actores del mercado de fraccionamiento de plasma crezcan durante el período de pronóstico.
Las perturbaciones en la cadena de suministro y la tremenda demanda de tratamientos eficientes para la terapia de COVID -19 han puesto a la industria de la investigación sanitaria en una situación crucial en la región APAC. Se han tomado medidas preventivas para controlar la propagación de esta pandemia. La pandemia de COVID-19 ha afectado ampliamente a las economías de la región APAC. Países como India, China, Japón y Corea del Sur se vieron afectados negativamente por la pandemia. La situación socioeconómica se vio gravemente afectada, con un aumento de la inflación negativa, el PIB y un aumento del desempleo regional. Países como China, Japón, Singapur y Corea del Sur están viendo un mayor interés en los ensayos clínicos. Los altos costos en los países occidentales también están contribuyendo al flujo de subcontratación de asuntos médicos a la región APAC. Para ampliar las ventas al mercado asiático, las empresas farmacéuticas están tomando conciencia de los entornos regulatorios nuevos y cambiantes para medicamentos, dispositivos y diagnósticos in vitro. En Asia se implementan con frecuencia regulaciones nuevas o mejoradas, incluidos cambios en las normas GMP, controles de precios de medicamentos y sistemas regulatorios de dispositivos médicos. Se requiere orientación y asesoramiento de terceros como parte de cualquier adquisición o mejora de los estándares actuales. Cada vez más, los proveedores de servicios de subcontratación externos desempeñan un papel más importante en el apoyo al mercado asociado en APAC. Sin embargo, el mercado está estabilizado en comparación con las fases iniciales de la pandemia, debido a los procedimientos de control, la concienciación entre la gente, la disponibilidad de vacunas y las políticas gubernamentales de apoyo a las empresas en el mercado relacionado.
Descripción general y dinámica del mercado
Se espera que el mercado de fraccionamiento de plasma en APAC crezca de 5.854,65 millones de dólares en 2021 a 9.433,53 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 7,1% de 2021 a 2028. El resto de APAC incluye países del sudeste asiático como Singapur, Malasia, Taiwán, Vietnam y otros países. Varios países han logrado un crecimiento significativo en los institutos médicos y de investigación, lo que, a su vez, conduce al crecimiento del mercado de fraccionamiento de plasma. Además, el creciente número de casos de trastornos asociados a la diabetes está impulsando aún más el desarrollo del mercado. Por ejemplo, según un informe publicado en la revista farmacéutica MDPI en 2020, se estima que la tasa de prevalencia de UPD es del 5,5%. Malasia ha sido clasificada como el mayor caso de diabetes registrado en Asia, con alrededor de 3,6 millones de pacientes. Para 2025, se espera que alrededor de siete millones de adultos tengan diabetes y potencialmente desarrollen UPD. Tales factores aumentarán la demanda del mercado de fraccionamiento de plasma.
Segmentos de mercado clave
< p>El mercado de fraccionamiento de plasma de APAC está segmentado en producto, aplicación, usuario final y país. El mercado de fraccionamiento de plasma de APAC, según el producto, se ha segmentado en inmunoglobulinas, albúmina, concentrados de factores de coagulación, inhibidores de proteasa y otros. Es probable que el segmento de inmunoglobulinas tenga la mayor participación del mercado en 2021. El mercado de fraccionamiento de plasma de APAC, según la aplicación, se segmenta en neurología, inmunología, hematología, cuidados intensivos, neumología y otros. En 2021, es probable que el segmento de Neurología tenga la mayor cuota de mercado. El mercado de fraccionamiento de plasma de APAC, basado en el usuario final, se segmenta en hospitales y clínicas, laboratorios de investigación clínica e institutos académicos. En 2021, es probable que el segmento de hospitales y clínicas tenga la mayor participación del mercado. Según el país, el mercado de fraccionamiento de plasma de APAC está segmentado en Australia, China, India, Japón, Corea del Sur y el resto de APAC. Japón tuvo la mayor cuota de mercado en 2021.Principales fuentes y empresas cotizadas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de fraccionamiento de plasma en APAC son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y la base de datos estadística, entre otros. Las principales empresas que figuran en el informe son Bharat Serums and Vaccines Limited (BSV); Laboratorio de Productos Bio Ltd.; CSL limitada; Grifols, SA; Kedrion SpA; Octapharma AG; PlasmaGen BioSciences Pvt. Limitado. Ltd.; y SK Plasma.
Informe de razones para comprar
- Comprender el panorama del mercado de fraccionamiento de plasma de APAC e identificar los segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno.
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de fraccionamiento de plasma de APAC.
- < span>Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado de fraccionamiento de plasma de APAC identificando segmentos de mercado con las ventas probables más prometedoras.
- Ayuda a tomar decisiones comerciales informadas desde un punto de vista perspicaz e integral. análisis del desempeño del mercado de varios segmentos del mercado de fraccionamiento de plasma de APAC.
- Obtener un pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región de APAC.
APAC Mercado de fraccionamiento de plasma Segmentación
Mercado de fraccionamiento de plasma APAC - Por producto
- Inmunoglobulina
- Inmunoglobulina intravenosa (IVIG)
- Inmunoglobulina subcutánea (SCIG)
- Albúmina
- Concentrados de factor de coagulación
- Inhibidores de proteasa
- Otros
Mercado de fraccionamiento de plasma de APAC: por Aplicación
- Neurología
- Inmunología
- Hematología
- Cuidados críticos
- Neumología
- Otros
Mercado de fraccionamiento de plasma de APAC: por usuario final
- Hospitales y clínicas
- Laboratorios de investigación clínica
- Institutos académicos
Mercado de fraccionamiento de plasma de APAC: por país
- Australia
- China
- India
- Japón
- Corea del Sur
- Resto de APAC
Mercado Fraccionamiento de plasma APAC: perfiles de la empresa
- Bharat Serums and Vaccines Limited ( BSV)
- Bio Products Laboratory Ltd.
- CSL Limited
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- PlasmaGen BioSciences Pvt. Limitado. Ltd
- SK Plasma
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Plasma Fractionation Market – By Product
1.3.2 APAC Plasma Fractionation Market – By Application
1.3.3 APAC Plasma Fractionation Market – By End User
1.3.4 APAC Plasma Fractionation Market – By Country
2. APAC Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy is Becoming More Widely Used
5.1.2 Players' Active Involvement in Market Developments
5.2 Market Restraints
5.2.1 Options for Non-Plasma Substitutes
5.3 Market Opportunities
5.3.1 Growth Potential in Developing Countries
5.4 Future Trends
5.4.1 Novel Diseases Getting Treated with Use of Plasma Therapy
5.5 Impact Analysis
6. Plasma Fractionation Market – APAC Analysis
6.1 APAC Plasma Fractionation Market Revenue Forecast and Analysis
7. APAC Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 APAC Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. APAC Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Overview
10.1.1.1.2 Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.3 Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.1 Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
10.1.1.1.4 Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.5 Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.2 China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.2.1 Overview
10.1.1.2.2 China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.2.3 China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.1 China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
10.1.1.2.4 China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.5 China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.3 India Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.3.1 Overview
10.1.1.3.2 India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.3.3 India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.1 India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
10.1.1.3.4 India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.5 India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.4 South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.4.3 South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.1 South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
10.1.1.4.4 South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.5 South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.5 Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.1.1.5.3 Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3.1 Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
10.1.1.5.4 Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.5 Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.6 Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3.1 Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
10.1.1.6.4 Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4.1 Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on APAC Plasma Fractionation Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Octapharma AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Kedrion S.p.A
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CSL Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Grifols, S.A.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio Products Laboratory Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bharat Serums and Vaccines Limited (BSV)
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 SK Plasma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 PlasmaGen BioSciences Pvt. Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
Table 3. Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
Table 7. China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
Table 11. India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
Table 15. South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 18. Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
Table 19. Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))
Table 23. Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic developments done by Companies
Table 27. Glossary of Terms, APAC Plasma Fractionation Market
LIST OF FIGURES
Figure 1. APAC Plasma Fractionation Market Segmentation
Figure 2. APAC Plasma Fractionation Market Segmentation, By Country
Figure 3. APAC Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in APAC Plasma Fractionation Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to APAC Plasma Fractionation Market
Figure 8. APAC Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. APAC Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. APAC Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. APAC Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. APAC Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. APAC Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. APAC Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. APAC Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. APAC Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. APAC Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. APAC Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. APAC Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. APAC Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. APAC Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. APAC Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. APAC Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. APAC Plasma Fractionation Market Overview, by Country (2018)
Figure 29. APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 32. India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 33. South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 34. Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 35. Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Impact of COVID-19 Pandemic in APAC Country Markets
Figure 37. Growth Strategies Followed by Major Market Players (%)
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- PlasmaGen BioSciences Pvt. Ltd.
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution